Status:
RECRUITING
Radiofrequency Ablation for BIII Thyroid Nodules
Lead Sponsor:
Columbia University
Conditions:
Indeterminate Bethesda III Thyroid Nodules
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this observational chart review study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of indeterminate thyroid nodules before and after RFA procedu...
Detailed Description
In the United States, there is an estimated 10% lifetime probability for developing a thyroid nodule. Up to 15% of these nodules will prove to be malignant. The incidence of thyroid cancer is increas...
Eligibility Criteria
Inclusion
- Indeterminate Bethesda III nodules that have been molecularly profiled benign with either Afirma Genomic Sequencing Classifier (GSC) or ThyroSeq v3 tests
Exclusion
- cardiac arrthymias
- pregnancy
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05189808
Start Date
August 1 2020
End Date
August 1 2027
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University
New York, New York, United States, 10032